SITC Resource Library

On January 7, 2021, leading experts in cancer immunotherapy presented the latest advances in cancer immunotherapy emerging from ESMO Virtual Congress 2020.

After attending this webinar, participants were able to:

• Describe advances in immune checkpoint inhibitor therapies for highly immunotherapy-responsive cancers including melanoma and renal cell carcinoma
• Outline novel immunotherapeutic strategies and implications for future cancer care
• Explain the rationale behind and implications of current combination immunotherapy studies

Webinar Faculty:

• Toni K. Choueiri, MD – Dana-Farber Cancer Institute
• Sumanta K. Pal, MD – City of Hope
• Lillian L. Siu, MD – Princess Margaret Cancer Centre, University Health Network
• Jeffery S. Weber, MD, PhD – NYU Langone Medical Center